20 results on '"Dağlı, Mustafa Necati"'
Search Results
2. Effects of grapeseed extract on doxorubicin-induced cardiotoxicity in rats
- Author
-
Adıyaman, Mehmet Şahin, Adıyaman, Özlem Aba, Dağlı, Adile Ferda, Karahan, Mehmet Zülkif, Kaya, İlyas, and Dağlı, Mustafa Necati
- Published
- 2021
- Full Text
- View/download PDF
3. The efficacy of CT for detection of right ventricular dysfunction in acute pulmonary embolism, and comparison with cardiac biomarkers
- Author
-
İn, Erdal, Aydın, Ayşe Murat, Özdemir, Cengiz, Sökücü, Sinem Nedime, and Dağlı, Mustafa Necati
- Published
- 2015
- Full Text
- View/download PDF
4. Effects of grapeseed extract on doxorubicin-induced cardiotoxicity in rats
- Author
-
Adıyaman, Mehmet Şahin, primary, Adıyaman, Özlem Aba, additional, Dağlı, Adile Ferda, additional, Karahan, Mehmet Zülkif, additional, Kaya, İlyas, additional, and Dağlı, Mustafa Necati, additional
- Published
- 2020
- Full Text
- View/download PDF
5. Prevention of doxorubicin-induced experimental cardiotoxicity by Nigella sativain rats
- Author
-
Adıyaman, Mehmet Şahin, Adıyaman, Özlem Aba, Dağlı, Adile Ferda, Karahan, Mehmet Zülkif, and Dağlı, Mustafa Necati
- Abstract
Doxorubicin (DOX) is an anthracycline cytotoxic chemotherapeutic drug that is commonly used in cancer treatment. A major side effect limiting the clinical use of DOX is cardiotoxicity due to oxidative injury. Nigella sativa(NS) is an annual flowering plant with antioxidant properties. Its seeds contain several bioactive constituents such as saturated and unsaturated fatty acids, thymoquinone, dithymoquinone, thymohydroquinone, and thymol. In this study, we investigated the effect of NS extract on DOX-induced cardiotoxicity.
- Published
- 2022
- Full Text
- View/download PDF
6. Copeptın Level in Coronary Artery Ectasıa
- Author
-
Seçen, Özlem, primary, Yalvaç, Özkan, additional, and Dağlı, Mustafa Necati, additional
- Published
- 2018
- Full Text
- View/download PDF
7. Effect of isoflavones on atherosclerosis in peritoneal dialysis patients
- Author
-
Şahbaz, Fatih, primary, Doğukan, Ayhan, additional, and Dağlı, Mustafa Necati, additional
- Published
- 2016
- Full Text
- View/download PDF
8. PP-594 - Copeptın Level in Coronary Artery Ectasıa
- Author
-
Seçen, Özlem, Yalvaç, Özkan, and Dağlı, Mustafa Necati
- Published
- 2018
- Full Text
- View/download PDF
9. OP-594 - Copeptın Level in Coronary Artery Ectasıa
- Author
-
Seçen, Özlem, Yalvaç, Özkan, and Dağlı, Mustafa Necati
- Published
- 2018
- Full Text
- View/download PDF
10. Atriyal Septal Defekt, Biküspit Aorta, Mental Reterdasyon ve Pektus Ekskavatum Birlikteliği: Olgu Sunumu
- Author
-
Dağlı, Mustafa Necati, primary, Doğdu, Orhan, additional, Çakmak, Tolga, additional, Sarıoğlu, Güney, additional, and Kobat, Mehmet Ali, additional
- Published
- 2015
- Full Text
- View/download PDF
11. Focusing on a complete blood cell parameter: mean platelet volume levels may be a predictor of coronary slow flow.
- Author
-
Yılmaz, Mücahid, Dağlı, Mustafa Necati, Uku, Ökkeş, Bilen, Mehmet Nail, Korkmaz, Hasan, Erdem, Kenan, and Kurtoğlu, Ertuğrul
- Subjects
BLOOD cells ,BLOOD platelets ,ATHEROSCLEROSIS ,CORONARY angiography ,THROMBOLYTIC therapy ,MYOCARDIAL infarction ,BLOOD flow measurement ,CORONARY circulation ,CORONARY disease ,HEMODYNAMICS ,PHARMACOKINETICS ,PROGNOSIS ,PREDICTIVE tests ,RETROSPECTIVE studies ,RECEIVER operating characteristic curves ,MEAN platelet volume ,DIAGNOSIS - Abstract
Background: The relationship between increased mean platelet volume (MPV) and atherosclerosis is well known. In the present study, MPV in patients with coronary slow flow (CSF) and in cases with normal coronary anatomy (NCA) was investigated and compared with the aim of identifying the relationship between CSF and MPV.Patients and Methods: We studied 40 patients previously determined via coronary angiography as having NCA and 40 patients with CSF in the coronary blood stream, as identified by thrombolysis in myocardial infarction square. Thus, a total of 80 patients from the Elaziğ Education and Research Hospital (Elaziğ, Turkey) were included in the present study retrospectively and laboratory and anamnesis information was scanned into their files. The relationship between MPV and CSF was studied.Results: MPV levels were observed to be significantly higher in the CSF group compared to the NCA group (10.05±1.3 and 8.6±0.6, p<0.001). In receiver operating characteristics analyses, it was determined that an MPV >9.05 measured in CSF patients at application had a predictive specificity of 77.5% and sensitivity of 77.5% for CSF (area under the curve: 0.825, 95% confidence interval [CI]: 0.726-0.924, p<0.0001). It was found that MPV level was an independent predictor of CSF (β=-600, p<0.001, 95% CI: -0.383 to -0.176).Conclusion: MPV is increased in patients with CSF when compared to patients with NCA. This finding supports the fact that MPV could be a predictor of CSF. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
12. Carotid artery stiffness in Behçet's disease.
- Author
-
Yolbaş, Servet, Gözel, Nevzat, Dağlı, Mustafa Necati, Koca, Süleyman Serdar, and Dönder, Emir
- Subjects
BEHCET'S disease ,CAROTID intima-media thickness ,CAROTID artery diseases ,ATHEROSCLEROSIS ,SKIN diseases - Abstract
Objective: Increased carotid arterial stiffness (CAS) is a predictor of subclinical early atherosclerosis as well as carotid intima-media thickness (cIMT). We aimed to determine CAS and cIMT in Behçet's disease (BD). Material and Methods: BD (n=49) and rheumatoid arthritis (RA) (n=64) patients and healthy controls (HC) (n=40) were included in the study. cIMT was measured. CAS indices, including arterial compliance (AC), arterial distensibility (AD), Young's elastic modulus (YEM), Peterson's elastic modulus (Ep), and β stiffness index (βSI) were measured based on the diameter-pressure relationship. Results: When compared to the HC group, the mean cIMT was significantly higher in the RA group (p=0.033), but it was not higher in the BD group. The CAS indices, including AD, AC, Ep, and βSI were not significantly different among the study groups. Moreover, the cIMT and CAS indices were not significantly different between active (n=20) and inactive BD patients, and these indices were not correlated with the scores of disease activity. AD, AC and Ep were significantly lower in the BD patients with a positive pathergy reaction than in those with a negative reaction. Conclusion: These results suggest that BD does not directly lead to arterial stiffness or to an increase in cIMT. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
13. QT dispersion and P wave dispersion in patients with fibromyalgia.
- Author
-
Yolbaş, Servet, Yıldırım, Ahmet, Düzenci, Deccane, Karakaya, Bülent, Dağlı, Mustafa Necati, and Koca, Süleyman Serdar
- Subjects
FIBROMYALGIA ,ELECTROCARDIOGRAPHY ,CARDIOVASCULAR diseases ,DIAGNOSIS - Abstract
Objective: Fibromyalgia (FM) is a chronic disease characterized by widespread pain. Somatic complaints associated with the cardiovascular system, such as chest pain and palpitations, are frequently seen in FM patients. P and QT dispersions are simple and inexpensive measurements reflecting the regional heterogeneity of atrial and ventricular repolarization, respectively. QT dispersion can cause serious ventricular arrhythmias. The aim of the present study was to evaluate QT dispersion and P wave dispersion in patients with FM. Material and Methods: The study involved 48 FM patients who fulfilled the established criteria and 32 healthy controls (HC). A standard 12-lead electrocardiogram was performed on all participants. QT dispersion was defined as the difference between the longest and the shortest QT intervals. Similarly, the differences between the shortest and longest P waves were defined as P wave dispersion. Results: The QT dispersion and corrected QT dispersion were shorter in the FM group compared with the HC group (p<0.001 for both). In terms of the P wave dispersion value, there was no significant difference between the FM and HC groups (p=0.088). Conclusion: Longer QT and P wave dispersions are not problems in patients with FM. Therefore, it may be concluded that fibromyalgia does not include an increased risk of atrial and/or ventricular arrhythmias. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
14. The Relationship between Computed Tomography Pulmonary Angiography Findings and Right Ventricular Dysfunction in Patients with Pulmonary Embolism.
- Author
-
İn, Erdal, Turgut, Teyfik, Kalkan, Mehmet, Karadağ, Müge Otlu, and Dağlı, Mustafa Necati
- Subjects
HEART ventricle diseases ,ANGIOGRAPHY ,CHI-squared test ,STATISTICAL correlation ,ECHOCARDIOGRAPHY ,RIGHT heart ventricle ,PULMONARY embolism ,RADIONUCLIDE imaging ,T-test (Statistics) ,DATA analysis software ,DESCRIPTIVE statistics ,MULTIDETECTOR computed tomography ,DISEASE complications ,DISEASE risk factors - Abstract
OBJECTIVES: In this study, we aimed to localize thrombus and to evaluate the relationship between the site of thrombus and right ventricular dysfunction (RVD) in patients with pulmonary embolism (PE) diagnosed with computed tomography pulmonary angiography (CTPA). MATERIAL AND METHODS: CTPA and echocardiography (ECHO) findings of 59 patients (35 male, 24 female) with PE diagnosed on CTPA were analysed retrospectively. The site of thrombus on CTPA was documented. Patients were divided into 2 groups according to ECHO findings as patients without RVD (group 1) and with RVD (group 2). RESULTS: The most frequent sites of thrombus formation were the right main pulmonary artery (33.8%) and right lower lobar artery (30.5%). It was observed that thrombus formation was significantly higher in the right system than that of the left (63.8% and 36.2%, respectively; p<0.01). ECHO findings revealed that 16 of the 59 patients had RVD. The number of patients who had thrombus in the right main pulmonary artery was significantly higher in group 2 (p<0.001). Pulmonary trunk diameter measured by CT was significantly lower in group 1 (28 mm±3.61) in comparison to that in group 2 (37 mm±5.88) (p<0.01). Systolic pulmonary artery pressure was significantly positively correlated with pulmonary trunk and right ventricular diameter (p<0.001). Sensitivity, specificity and positive predictive value of CTPA in detecting RVD were 87.5% (14/16), 95.3% (41/43) and 87.5% (14/16), respectively. CONCLUSION: It was observed that the probability of RVD was higher in patients with thrombus in right main pulmonary artery. There was a strong relationship between the pulmonary trunk and right ventricular diameter measured by CT and RVD observed on ECHO. It was suggested that CTPA is a reliable imaging method for detecting RVD in patients with PE. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
15. The effects of benfotiamin in experimental acute myocardial infarction
- Author
-
Çakmak, Tolga, Dağlı, Mustafa Necati, and Kardiyoloji Anabilim Dalı
- Subjects
Bbenfothiamine ,Kardiyoloji ,Myocardial infarction ,Cardiovascular diseases ,Heart diseases ,Cardiology ,Isoproterenol - Abstract
ÖZETMiyokard İnfarktüsü (MI) Kardiyovasküler Hastalıklar içinde ölüme en fazla sebebiyet veren hastalık grubudur. Isoproterenol (ISO), deneysel akut miyokart infarktüsü modeli oluşturmada sık kullanılan -adrenerjik bir ajandır. Benfotiamin Vitamin B1'in yağda çözünen hali olup antioksidan etkileri bilinmektedir. Bu çalışmada ISO ile deneysel olarak akut miyokart infarktüsü oluşturulan sıçanlarda, antioksidan etkisi bilinen benfotiaminin kalp dokusu üzerine etkilerinin araştırılması amaçlanmıştır.Çalışmada, 24 adet 8 haftalık Wistar albino cinsi erkek sıçanlar kullanıldı. Deney hayvanları her grupta 6 hayvan olacak şekilde 4 gruba ayrıldı. Kontrol grubuna (Grup I) deney süresi olan 14 gün boyunca herhangi bir uygulama yapılmadı. Benfotiamin (grup II) grubuna benfotiamin 70mg/kg/gün dozunda oral yolla verildi. MI (grup III) ve MI + benfotiamin (grup IV) grublarına 150 mg/kg isoproterenol, 24 saat ara ile 2 kez intraperitoneal olarak verildikten sonra MI grubuna deney süresince herhangi bir uygulama yapılmazken MI + benfotiamin grubuna 70mg/kg/gün dozunda benfotiamin oral yolla verildi. Deney sonunda tüm sıçanlar anestezi altında dekapite edilerek kalp dokuları çıkarıldı. Kalp dokularına Hemotoksilen&Eozin, Masson Trikrom, Bax ve Kaspaz 3 İmmunohistokimyası ve TUNEL boyama yapıldı. İmmünohistokimyasal boyamada; kontrol ve benfotiamin gruplarına göre MI grubunda Bax ve Kaspaz 3 immünreaktivitesinde belirgin bir artış gözlenirken, MI + benfotiamin grubunda azalma izlendi. TUNEL boyamada ise kontrol ve benfotiamin gruplarına göre MI grubunda apoptotik hücre artışı belirgin olarak gözlenirken MI + benfotiamin grubunda azalma izlendi.Sonuç olarak, deneysel olarak akut miyokart infarktüsünün oluşturduğu hücresel değişikliklere karşı benfotiamin'in koruyucu etkilerinin gösterilmesi, MI komplikasyonlarını önlemek amacıyla benfotiamin ile ilişkili tedavi yaklaşımlarının denenmesinin yararlı olabileceği ve bu konuda kapsamlı araştırmaların yapılması gerektiği kanaatine varılmıştır.Anahtar Kelimeler: Miyokart İnfarktüsü, benfotiamin, isoproterenol ABSTRACTTHE EFFECTS OF BENFOTIAMIN IN EXPERIMENTAL ACUTE MYOCARDIAL INFARCTION Myocardial Infarction (MI) is a group of diseases that cause the most deaths in cardiovascular diseases. Isoproterenol (ISO), is a -adrenergic agent that commonly used for creating the experimental acute myocardial infarction model. Benfotiamin is fat-soluble form of vitamin B1 and known to have antioxidant effects. In this study, we aimed to investigate the effects of benfotiamin, that has antioxidant properties, on heart tissue of rats with experimental acute myocardial infarction induced by ISO. In the study, 8 week-age, 24 male Wistar rats were used. Animals were divided into 4 different groups with 6 animals in each group. The control group (Group I) was without any application during the 14 days-experiment period. In benfotiamin (group II) group benfotiamin was given orally at a dose of 70mg/kg/day. In both MI (group III), and MI + benfotiamin (group IV) groups 150 mg / kg intraperitoneal isoproterenol was administered 2 times with 24 hours interval and after this application no other application was administered to MI group but on the other hand 70mg/kg/day benfotiamin was given orally to MI + benfotiamin group. At the end of the experiment, all rats were decapitated, and heart tissues were removed under anaesthesia. Heart tissues were evaluated immunohistochemically with Haematoxylin & eosin, Masson's trichrome, Bax and caspase 3 and TUNEL staining was performed. Immunohistochemical staining revealed a marked increase in bax and caspase 3 immunoreactivity in MI group in comparison with the control and benfotiamin groups and decrease was observed in MI + benfotiamin group. TUNEL staining revealed increased apoptotic cells in MI group in comparison with the control and benfotiamin groups and a reduction was observed in MI + benfotiamin group. As a result, we observed the protective effects of benfotiamin against the cellular changes in experimental acute myocardial infarction and so benfotiamin may be a useful approch to challenge for MI associated complications.Key Words: Myocardial infarction, benfotiamin, isoproterenol 77
- Published
- 2014
16. Koroner arter ektazisinde copeptin seviyesi
- Author
-
Yavçin, Özkan, Dağlı, Mustafa Necati, and Kardiyoloji Anabilim Dalı
- Subjects
Kardiyoloji ,Coronary disease ,Heart diseases ,Coronary vessels ,Copeptin ,Cardiology ,Coronary circulation - Abstract
Koroner kalp hastalığı önemli mortalite ve morbidite nedenidir. Koroner arter ektazisi (KAE), koroner arterin lokalize yada diffüz olarak komşu normal koroner arter çapından 1.5 kattan daha fazla genişlemesidir. KAE?nin etyopatogenezi ve patofizyolojisi tam olarak açıklanamamıştır. Ateroskleroz, konjenital nedenler, inflamatuar veya bağ doku hastalıkları sonucu gelişen KAE genellikle asemptomatik seyretmekle birlikte myokard iskemisine ve enfarktüsüne de yol açabilir. Copeptin plazma konsantrasyonları AVP plazma konsantrasyonları ile koleredir. Kortizole oranla endojen stres seviyesini daha iyi yansıttığı gösterilmiştir. Kardiyovasküler hastalıklar, inme, sepsis, şok gibi durumlarda plazmada copeptin hızlı bir yükseliş sergilemektedir. Bu yükselişte tanısal ve prognostik değer taşımaktadır. Literatürde KAE saptanan hastalarda serum copeptin düzeylerini değerlendiren bir çalışma bulunmamaktadır. Biz bu çalışmada etiyopatogenezi net olarak açıklanamayan koroner ektazide copeptinin bir rolünün olup olmadığını araştırmayı amaçlandı. Çalısmaya Ekim 2012- Mart 2013 tarihleri arasında Fırat Universitesi Tıp Fakultesi Kardiyoloji Kliniği Katater Laboratuarında prospektif olarak, KAE tanısı alan 44 olgu ile kontrol grubu olarak normal koroner anatomiye (NKA) sahip 44 olgu olmak üzere toplam 88 olgu rastgele yontem ile secildi. Olgulardan alınan kan örneklerinin santrifüj edilmesi ile elde edilen ve -70 derecede saklanan serumlardan copeptin seviyeleri ELİZA yöntemi ile çalışıldı. Ayrıca rutin biyokimyasal parametre düzeyleri otoanalizör yardımı ile ölçüldü.Grupların ölçülen copeptin düzeyleri KAE?li grupta daha yüksek olmakla birlikte istatistiksel olarak anlamlı değildi (700,00±190,09?e karşın, 632,36±217,6; p=0.81). Subgrup analizinde diffüz KAE (Tip I, II, III) grubunda ortalama copeptin düzeyi 239,08 ± 66,35 pg/ml, Tip IV KAE(segmental ektazi) grubunda ise 906,62± 266,19 pg/ml olarak tespit edildi. Koroner arter ektazisi olgularında copeptin düzeylerini istatistiksel olarak anlamlılık seviyelerine ulaşmayan derecede yüksek bulduk. Ayrıca segmental ektazilerde (Tip IV KAE) copeptin düzeyleri NKA ve diffüz KAE (Tip I, II, III) lere oranla daha yüksek bulunmuş olup segmental ektazilerin etyopatogenezinde aterosklerozun daha büyük rol oynadığını destekleyebilir. KAE li hastalarda daha etkin bir tedavi protokolünün ortaya konması için KAE patofizyolojisinin tam olarak aydınlatılabildiği daha kapsamlı çalışmalara ihtiyaç vardır. Bizim çalışmamız bu konuda öncü çalışmalardan biri olup bu konuda yapılacak ileri çalışmalara ışık tutacağı kanısına varılmıştır. Anahtar sözcükler: Koroner arter ektazisi, copeptin, koroner arter hastalığı Coronary heart disease is an important cause of mortality and morbidity. Coronary artery ectasia (CAE), is localized or diffuse enlargement of coronary artery more than 1.5 times in diameter in comparison with adjacent normal coronary artery. Etiology and pathophysiology of CAE is not fully elucidated. CAE caused by atherosclerosis, congenital, inflammatory, or connective tissue diseases is usually asymptomatic but may cause myocardial ischemia and infarction. Plasma concentrations of copeptin are correlated with AVP plasma concentrations. It is more reflective for endogenous stress than the cortisol. In cardiovascular diseases, stroke, sepsis and shock a rapid rise in plasma copeptin is seen. This increase have diagnostic and prognostic value. In the literature, there are no studies evaluating the copeptin levels in serum in patients with CAE. In this study, we aimed to investigate whether copeptinin has a role in coronary artery ectasia etiopathogenesis.Between October 2012-March 2013 in Firat School of Medicine, Department of Cardiology Catheter Laboratory we evaluated randomly 44 patients with a diagnosis of CAE and 44 normal coronary anatomy (NCA) with a total of 88 cases prospectively. Blood samples obtained from patients were stored at -70 º C and copeptin levels in sera were measured by ELISA method. Other necessary biochemical parameters were measured with autoanalyzer.Copeptin levels in CAE group were higher than other groups but were not statistically significant (700.00 ± 190.09 versus, 632.36 ± 217.6, p = 0.81). In subgroup analysis mean copeptin level of the diffuse CAE (Type I, II, III) was 239.08 ± 66.35 pg / mland in Type IV CAE (segmental ectasia) group was 906.62 ± 266.19 pg / ml.Although it did not reach to statistical significance level in patients with CAE high copeptin levels were found. In segmental ectasia (Type IV CAE) group copeptin levels were higher than diffuse CAE (Type I, II, III) and NCA so atherosclerosis is thoght to play a major role in the etiopathogenesis of especially diffuse CAE. For more effective treatment protocols in patients with CAE, more comprehensive studies to demonstrate CAE pathophysiology is needed. Our study is one of the pioneers in this field and will shed light for further studies.Key words: Coronary artery ectasia, copeptin, coronary artery disease 55
- Published
- 2013
17. Doksorubisin ile oluşturulmuş deneysel kardiyotoksisite üzerine alıç'ın etkisi
- Author
-
Adiyaman, Mehmet Şahin, Dağlı, Mustafa Necati, and Kardiyoloji Anabilim Dalı
- Subjects
Kardiyoloji ,Toxicity ,Hawthorn ,Doxorubicin ,Heart diseases ,Cardiology ,Heart failure - Abstract
Kalp yetmezliği (KY) hemodinamik anormallikler, bozulmuş egzersiz kapasitesi, nörohormonal aktivasyon, hızlı progresyon ile karakterize ve yüksek morbidite ve mortalite ile seyreden kompleks bir sendromdur. KY, iskemik, hipertansif, infektif, inflamatuar, immün, endokrin, metabolik, genetik ve neoplastik nedenlere bağlı olarak gelişebilir. Hastaların %30-40'ının tanıdan sonra 1 yıl içinde, %60-70'inin de 5 yıl içinde KY'nin kötüleşmesi veya ventriküler malin aritmi nedeniyle kaybedilmektedir. Alıç, içerisinde antienflamatuar, antiaterosklerotik, antioksidatif etki gösteren bileşikler içermektedir. Alıç üzerinde yapılan sınırlı sayıdaki çalışmalarda kardiyoprotektif etkilerinin olduğu bildirilmiş olmakla beraber net bir bilgi ortaya konulamamıştır. Ayrıca KY olan hastalarda alıcın nasıl bir etkisinin olacağı da bilinmemektedir. Çalışmamızda doksorubisin ile oluşturulmuş kardiyotoksik deneysel modelinde Alıcın kardiyoprotektif etkilerinin olup olmadığını araştırmayı amaçladık.Spraque Dawley türü erkek ratlar Kontrol (Grup I), Doksorubisin (Grup II), Alıç (Grup III) ve Alıç+Doksorubisin (Grup IV) olmak üzere 7'şerli dört gruba ayrıldı. Grup I ve Grup II'ye standart beslenme uygulandı. Grup III ve Grup IV'e standart beslenmeye ek olarak, her rat için 520 mg alıç ekstresi oral yolla verildi. Takiplerin 28. gününde Grup II ve Grup IV'e intraperitoneal enjeksiyon yöntemiyle 10 mg/kg tek doz doksorubisin uygulandı. Bütün denekler 35 gün süreyle takip edildi. 35. gün Ratlar dekapite edilerek kan serumu ve kalp dokusu alındı. Kan serumundan NT-pro BNP, CK, CK-MB ve glukoz düzeyleri çalışıldı. Histopatolojik olarak da kalp dokusunda miyosit dizilim bozukluğu, miyosit hipertrofisi ve fibrozise bakıldı.Grup II'de NT-pro BNP, CK ve CK-MB düzeyleri Grup I'e göre yüksek saptandı. Grup III ve Grup IV'de Grup II'ye göre NT-pro BNP, CK ve CK-MB düzeyleri daha düşük bulundu. Grup III'de Grup IV'e göre sadece glukoz anlamlı olarak düşük iken, diğer parametreler açısından anlamlı fark izlenmedi. Histopatolojik değerlendirmede ise Grup II'de Grup I'e göre miyosit dizilim bozukluğu, miyosit hipertrofisi, fibrozis daha yüksek saptandı. Grup III'te Grup I'e göre miyosit hipertrofisi, fibrozis yüksek iken; miyosit dizilim bozukluğu açısından daha anlamlı fark izlendi. Grup III ve Grup IV'te Grup II'ye göre miyosit dizilim bozukluğu, miyosit hipertrofisi, fibrozis daha az derecede izlendi. Ancak bu istatistiksel olarak anlamlı seviyeye ulaşmadı. Grup III ve Grup IV arasında histopatolojik parametreler açısından anlamlı fark izlenmedi.Sonuç olarak; alıç, kardiyotoksisite durumunda ya da kardiyotoksik olabilecek durumlarda kardiyoprotektif olarak kullanılabileceği ancak bu etkisinin de sınırlı olduğunu gösterdik. Bunun nedeni ise alıcın tek başına verildiğinde, nedenini açıklayamadığımız şekilde düşük derecede de olsa miyokardiyal hasar oluşturması ile açıklamaktayız. Bu hasarı da alıcın birçok nöroendokrin peptit içermesinden dolayı, farklı fizyopatolojik etkileşime girerek oluşturduğunu düşünmekteyiz. Dolayısı ile alıcın paramedikal tedavide yaygın olarak kullanılıyor olması, bu sonucumuzun da bilimsel açıdan önemli olduğunu düşündürmektedir.Anahtar kelimeler: Kalp yetmezliği, alıç, kardiyotoksisite, doksorubisin, Hearth failure (HF) is a complex syndrome, characterized by hemodynamic abnormalities, impaired exercise capacity, neurohormonal activation and rapidly progression and progress with higher mortality and morbidity. HF can develop by ischemic, hypertensive, infective, inflammative, immune, endocrine, metabolic, genetic and neoplastic reasons. 30%-40% of patient lost in first year of diagnose, and 60%-70% of them lost within 5 years by worsening HF or ventricular malign arhythmia. Crataegus Oxyacantha ingredients antiimflammation, antiatherosclerotic, antioxidative contains. There are limited numbers of studies on Crataegus Oxyacantha, reported its cardioprotective effects but could not describe a clear effect. Furthermore, it is not known even its effects on patients with cardiac failure. In our study, we searched if Crataegus Oxyacantha have cardioprotective effects on Doxorubicin induced cardiotoxicity or not.Spraque Dawley species male rats Control (group I), Doxorubicin (Group II), Crataegus Oxycantha (group III) and Doxorubicin + Crataegus Oxycantha (group IV) divided into four group, each group have 7 rats. Group I and Group II had standart nutrition. In Group III and Group IV for each rat had 520 mg per oral Crataegus Oxyacantha extretes added to standart nutrition. At 28. day of follows, 10 mg/kg one dose doxorubicin admistrated in intraperitoneal area. All subjects were followed for 35 days period. After 35 days all subjects decapitated, then blood serum and hearth tissues achived. In blood serum NTpro BNP, CK, CK-MB and glucose levels were searched. For histopathological resarch, hearth tissue searched for myocyte disarray, myocyte hypertrophia andfibrosis.N-terminal pro BNP, CK and CK-MB levels detected higher in group II than group I. In group III and Group IV NTpro BNP, CK and CK-MB levels detected lower than group II. Group III and Group IV glucose levels were significantly lower, there were no significant differences between other parameters. In histopathological resarch, in group II, myocytedisarray, myocyte hypertrophia and fibrosis found higher than group I. In group III myocyte hypertrophia and fibrosis are higher than group I, but there was more significant difference in myocyte disarray. In group III and group IV myocyte disarray, hypertrophia and fibrosis observed lower levels than group II. But that could not reach important statistically different levels. Between group III and group IV, there were no statistical difference for histopathological parameters.In conclusion; we showed, Crataegus Oxyacantha, can be use in cardiotoxicity or under risk of cardioxicity, it can be cardioprotective, but this effect is also limited. We can explain this condition, reciever take alone even only a low dose, there can be occur a minimal myocardial destructive effect. Because reciver contains many neuroendocrine peptide, we think, this caused by physiopathological counterreaction. Because it is using in paramedical treatment, it shows, our result is important for scientific point of view.Key Words: Hearth failure, crataegus oxyacantha, cardiotoxicty, doxorubicin 74
- Published
- 2011
18. Akut allerjik reaksiyonun diyastolik kalp fonksiyonları üzerine etkisi
- Author
-
Kaya, Oğuz Kaan, Dağlı, Mustafa Necati, and Kardiyoloji Anabilim Dalı
- Subjects
Kardiyoloji ,Serotonin ,Diastole ,Cardiology ,Heart failure ,Allergy and immunology ,Histamine - Abstract
Diyastolik kalp yetmezliği korunmuş sistolik fonksiyonlara rağmen kalp yetmezliği semptomlarının görülmesidir. Prognozu sistolik disfonksiyondan daha iyi olmasına rağmen bilinen bir mortalite ve morbidite nedenidir. Allerjik reaksiyonlarda ortaya çıkan aktif sitokinler gerek direk toksik etki ile gerekse koroner spazm yaparak kalbin diyastolik fonksiyonlarını bozabileceği düşüncesindeyiz. Çalışmamızda akut allerjinin kalbin diyastolik fonksiyonları üzerine etkilerini araştırmayı amaçladık.Çalışmaya; Mayıs 2010 ? Aralık 2010 tarihlerinde Fırat Üniversitesi Tıp Fakültesi Acil Servisine döküntü, kaşıntı nedeniyle başvuran ve klinik ve laboratuvar bulgularına dayanılarak allerji tanısı alan, rastgele seçilmiş 50 hasta allerji grubu olarak alındı. Kontrol grubu olarak klinik ve laboratuar verilerine dayanılarak allerji dışlanmış 30 sağlıklı gönüllü birey olmak üzere toplam 80 hasta rastgele yöntem ile seçildi. Hastaların rutin biyokimyasal parametreleri ve allerji tanısı koymak için serotonin, histamin seviyelerine bakıldı. Ekokardiyografi ile E, A oranları, DT, İVRT, mitral lateral anulus doku doppler hızları, renkli M mod akım ilerleme hızları değerlendirildi.Bazal sistolik fonksiyonlar, boşluk çapları ve duvar kalınlıkları ile biyokimyasal parametreler karşılaştırıldığında iki grup arasında fark yoktu. Ancak allerji grubunda 0. gün ile 5. gün bakılan ekokardiyografi değerleri arasında renkli M mod akım ilerleme hızları, E oranları, E/A oranları ile mitral lateral anulus doku doppler hızları arasında anlamlı fark vardı (Vp 0. gün- 45.10 ± 11.03 cm/sn, Vp 5. gün- 51.38 ± 6.86 cm/sn, E 0. gün- 3.31 ± 0.88 m/sn, E 5. gün- 3.12 ± 0.88 m/sn, E/A 0. gün- 1.76 ± 0.56, E/A 5. gün- 1.55 ± 0.49, Sm 0. gün- 0.04 ± 0.02 m/sn, Sm 5. gün- 0.05 ± 0.01 m/sn, Em 0. gün- 0.11 ± 0.46 m/sn, Em 5. gün- 0.10 ± 0.03 m/sn, p
- Published
- 2011
19. Koroner yavaş akım da apelin ve vaspin düzeyleri
- Author
-
Karaş, Düzgün, Dağlı, Mustafa Necati, and Kardiyoloji Anabilim Dalı
- Subjects
Kardiyoloji ,Coronary disease ,Adipokines ,Heart diseases ,Blood flow velocity ,Cardiology ,Apelin ,Atherosclerosis ,Coronary circulation - Abstract
Etyolojisinde aterosklerozun suçlandığı Koroner yavaş akım (KYA) koroner arter anatmisinin normal ya da normale yakın olanlarda anjiografi sırasında distal vasküler yapılara opak madde ilerleyişinin yavaş olmasıdır. Nedeni tam olarak aydınlatılamamıştır. Koroner yavaş akımın fizyopatolojisinde, mikrovasküler disfonksiyon, endotel ve vazomotor disfonksiyon ile oklüziv hastalıkların rol oynadığı düşünülmektedir.Adipositokinlerden olan apelin ve vaspin yeni tanımlanmışlardır. Apelin ve vaspinin metabolik etkileri ve karbonhidat metabolizması üzerine etkileri bilinmesine rağmen, koroner aterosklerozdaki rolleri henüz tam olarak bilinmemektedir. Etiyopatogenezi tam olarak bilinmeyen KYA'ın gelişiminde apelin ve vaspinin etkileri bilinmemektedir. Bu konuda yapılmış herhangi bir çalışma bulunmamaktadır. Biz bu çalışmada aterosklerozun bir varyantı kabul edilen KYA, KAH ve normal koroner anatomili vakalarda serum apelin ve vaspin düzeylerini karşılaştırmayı, apelin ve vaspinin koroner arter hastalığının belirlenmesinde ve öngörülmesinde kabul edilen klasik risk faktörleri arasındaki yerini ve değerini araştırmayı amaçladık.Çalışmaya 30 kişilik Koroner Yavaş Akım (KYA) ve 60 kişilik kontrol grubu (30 Normal Koroner Anatomi ile 30 kişilik KAH grubu ?en az bir koroner arterinde % 50 veya daha fazla stenoz tespit edilen 30 koroner arter hastası grubu) olmak üzere toplam 90 kişi alındı.Apelin seviyesini KAH grubunda NKA grubuna göre belirgin olarak düşük bulduk. İlave olarak Vaspin seviyesini kontrol grubuna göre YKA grubunda göreceli olarak daha düşük bulduk.Sonuç olarak etyolojisinde aterosklerozun rol oynadığı düşünülen YKA'da vaspin seviyeleri daha düşük bulundu. Bu bulgular vaspinin YKA oluşumunda rol oynayabileceğini düşündürebilir. Ancak vaspin seviyeleri düşük olduğundan mı KYA'nın oluşumuna neden olmakta yoksa KYA gelişiği için mi seviyelerinin düştüğü bilinmemektedir.Anahtar kelimeler: Koroner arter hastalığı, apelin, vaspin, koroner yavaş akım. Coronary Slow Fluid which is blamed for playing a role in the etiology of atherosclerosis is the slow movement of opac substance to distal vascular area in people with normal or subnormal coronary artery anatomy when coronaryangiography (CAG) is performed. Vasomotor disorders, oxygen- hemoglobin inappropriateness, microscular diseases and endothelial dysfunctions accused of ethyopathogenesis of Coronary Slow Fluid. On the other hand in spite of many speculations, ethyology that accused of capillery microcirculation insufficiency is a current question mark still. Although all cardiology specialists recognise Coronary Slow Fluid (CSF) well, there aren?t sufficient knowledge about clinical importance of this diseases.Apelin and vaspin which are two of the adipocytokines have been idenfied recently. Altought metabolic effects and effects on carbonhydrate metabolism of apelin and vaspin have been known, their roles on occurence of coronary athersclerosis has no been fully known yet. Currently, effect of apelin and vaspin on ethyopathogenesis of Coronary Slow Fluid can not be known. There is not any experiment about this matter. We aimed to comparison of plasma apelin and vaspin levels in CSF, coronary artery disease (CAD) and normal coronary artery (NCA) and research that value of apelin and vaspin amongst other classical risk factors that accepted in CAD.Totally subjects 90 is interned to study that 30 subjects CSF, 30 subjects is CAD and 30 subjects is control group (Normal Coronary Artery: NCA)We found apelin level relatively lower in coronary artery disease (CAD) compared to the Normal Coronary Artery (NCA) group. In addition, we also found vaspin level relatively lower in Coronary Slow Fluid (CSF) compared to the Normal Coronary Artery (NCA) group and coronary artery disease (CAD) group.In conclusıon, the levels of vaspin was found lower in Coronary Slow Fluid (CSF) in which atherosclerosis is considered to play a role in its etiology. This findings may suggest that vaspin may pay a role in the occurence of Coronary Slow Fluid (CSF). However, it is not known whether low levels of vaspin caused the occurence of Coronary Slow Fluid (CSF) or the low levels of those are resulted from the Coronary Slow Fluid (CSF).Key words: Coronary artery disease, apelin, vaspin, coronary slow fluid. 89
- Published
- 2010
20. Serum salusin-α levels in systemic lupus erythematosus and systemic sclerosis.
- Author
-
Koca SS, Özgen M, Işık B, Dağlı MN, Üstündağ B, and Işık A
- Abstract
Objective: Systemic lupus erythematosus (SLE) and systemic sclerosis (SSc), chronic inflammatory diseases, demonstrate an increased incidence of cardiovascular manifestations and subclinical atherosclerotic disease. Salusin-α is a novel bioactive peptide that suppresses the formation of macrophage foam cells, and its serum level is significantly lower in patients with angiographically proven coronary artery disease. The aims of the study were to assess serum salusin-α level and its potential association with the predictors of atherosclerosis in SLE and SSc., Material and Methods: The study included 20 SLE and 22 SSc patients and 23 healthy controls (HC). All of the participants were female. Tumour necrosis factor-α (TNF-α), IL-6 and salusin-α levels, homeostasis model assessment for insulin resistance (HOMA-IR) index and common carotid intima-media thickness (IMT) were determined., Results: Salusin-α levels were lower and the IMTs were higher in the SLE and SSc groups than in the HC group. The salusin-α level was correlated with neither the disease activity scores nor cytokine levels and IMT in the SLE and SSc groups, although it was correlated with triglyceride level in the SLE group (r=-0.564, p=0.012), and with HOMA-IR index in the HC group (r=0.485, p=0.019)., Conclusion: The present preliminary study may support the idea that SSc leads to subclinical atherosclerosis, as in SLE. Moreover, it can be concluded that the decreased salusin-α levels in SLE and SSc may contribute to subclinical atherosclerosis. However, further studies with larger sample size are needed to demonstrate this contribution in SLE and SSc.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.